Drugs by condition
Drugs approved for hepatitis b
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
9
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
6
New molecular entities and new biologics
In development
30
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for hepatitis b.
- Hibsago (Bepirovirsen Sodium) · Glaxosmithkline NovelPriority reviewOct 20, 2026
- Keytruda Qlex (Pembrolizumab, Berahyaluronidase Alfa-Pmph) · Merck Sharp Dohme NovelAccelerated approvalPriority reviewSep 19, 2025
- Vemlidy (Tenofovir Alafenamide Fumarate) · Gilead Sciences INC Nov 10, 2016
- Keytruda (Pembrolizumab) · Merck Sharp Dohme NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanSep 4, 2014
- Viread (Tenofovir Disoproxil Fumarate) · Gilead Sciences INC Priority reviewOrphanJan 18, 2012
All approved drugs for hepatitis b, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 22 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Endoglycosidase (1)
- Keytruda Qlex Pembrolizumab, Berahyaluronidase Alfa-Pmph · Merck Sharp Dohme · 2025
Programmed Death Receptor-1 Blocking Antibody (1)
- Keytruda Pembrolizumab · Merck Sharp Dohme · 2014
Interferon alpha (1)
- Pegasys Peginterferon Alfa-2a · Pharmaand Gmbh · 2002
Class not listed in FDA's data (6)
- Hibsago Bepirovirsen Sodium · Glaxosmithkline · 2026
- Baraclude Entecavir · Bristol Myers Squibb · 2005
- Viread Tenofovir Disoproxil Fumarate · Gilead Sciences INC · 2001
- Vemlidy Tenofovir Alafenamide Fumarate · Gilead Sciences INC · 2016
- Viread Tenofovir Disoproxil Fumarate · Gilead Sciences INC · 2012
- Baraclude Entecavir · Bristol Myers Squibb · 2005
Drugs in development for hepatitis b
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ElebsiranVIR-2218, BRII-835Phase 38 trials
Vir Biotechnology, Inc. · Viral Hepatitis, Hepatitis D, Chronic, Chronic Hepatitis B Virus (HBV) Infection
- HydronidoneF351Phase 35 trials
Beijing Continent Pharmaceutical Co, Ltd. · Liver Fibrosis, Chronic Hepatitis B With Hepatic Fibrosis, Liver Fibrosis in Chronic Hepatitis B
- VIR-3434TobevibartPhase 35 trials
Vir Biotechnology, Inc. · Viral Hepatitis, Hepatitis D, Chronic, Hepatitis B, Chronic
- GST-HG141Phase 33 trials
Fujian Akeylink Biotechnology Co., Ltd. · Chronic Hepatitis b, Chronic Hepatitis B
- TAFPhase 33 trials
Gilead Sciences · HIV-1-infection, Chronic Hepatitis B
- TQA3605Phase 33 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis b, Chronic Hepatitis B, HBV Infection With LLV
- HRS-5635Phase 32 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Chronic Hepatitis B, Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
- Inactivated Polio vaccinePhase 32 trials
LG Chem · Diphtheria, Tetanus, Pertussis
- TDFPhase 32 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection
- BK1803Phase 31 trial
Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus
- GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial
GC Biopharma Corp · Hepatitis B
- UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials
Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1
- Peg-IFN-αpegylated interferonPhase 26 trials
Brii Biosciences Limited · Chronic Hepatitis B, Chronic Hepatitis B Virus (HBV) Infection, Hepatitis B, Chronic
- TVAX-008Phase 24 trials
Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Chronic Hepatitis B, HBV Infection, Chronic Hepatitis B Virus
- HT-101Phase 23 trials
Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection
- HT-102Phase 23 trials
Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection
- NAsNucleoside analogs, acidPhase 23 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B, HBV Infection With LLV
- BRII-179Phase 22 trials
Brii Biosciences Limited · Chronic Hepatitis B Virus (HBV) Infection, For Treatment of Chronic Hepatitis B Virus Infection
- GST-HG131Phase 22 trials
Fujian Akeylink Biotechnology Co., Ltd. · Chronic Hepatitis B
- RBD1016Phase 22 trials
Ribocure Pharmaceuticals AB · Chronic Hepatitis D, Chronic Hepatitis b
More on hepatitis b: recruiting trials · published research
Related in infectious disease and vaccines: HIV · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection · Fungal infections
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.